chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Rash papular, Vaccination site erythema
Clinical narrative: Case number PHHY2013US127768 is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 498429) web site on 11 Nov 2013. This report refers to an 11-years-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: X12013) intramuscularly in the left arm, VARIVAX (other manufacturer, batch number: AC52B085AA) intramuscularly in the right arm on 02 Aug 2013. On 03 Aug 2013, he experienced erythematous area around the vaccination site and small pinpoint papules in the center of rash in the left arm. The outcome of the events was reported as complete recovery.
Age: 39.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Vaccination site pain, Vaccination site warmth
Clinical narrative: Case number PHHY2013US117225 is an initial spontaneous report received via vaccine adverse event reporting system (VAERS reference number: 498444) on 15 Oct 2013. This report refers to a 39-year-old male patient. His medical history included bronchitis and concomitant medications were not reported. He was vaccinated with meningococcal vaccine (manufacturer and batch number: not reported hence conservatively taken as MENVEO INN) subcutaneously in the right arm on 01 Aug 2013. On 03 Aug 2013, he experienced circular rash with a circumference of 7 inches to the right triceps. It was also stated that the vaccination site was tender, itchy and warm to touch with redness. The outcome of the events was reported as condition unchanged.
Age: 25.0
Sex: M
Vaccine: MNQ
Symptoms: Activities of daily living impaired, Eyelid function disorder, Fatigue, Lethargy, Musculoskeletal stiffness
Clinical narrative: Case number PHHY2013US127770 is an initial spontaneous report received from  vaccine adverse event reporting system (VAERS reference number: 498545) web site on 11 Nov 2013. This report refers to a 25-years-old male patient. his medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: A12026) intramuscularly in the right arm on 23 Jul 2013. On 24 Jul 2013, he could not open his eyes due to fever. He also had stiff neck, fatigue and lethargy. He could not go for work. He went to emergency room and was treated with TYLENOL. The outcome of the events was reported as complete recovery.
Age: 25.0
Sex: M
Vaccine: MNQ
Symptoms: Pyrexia
Clinical narrative: Case number PHHY2013US127770 is an initial spontaneous report received from  vaccine adverse event reporting system (VAERS reference number: 498545) web site on 11 Nov 2013. This report refers to a 25-years-old male patient. his medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: A12026) intramuscularly in the right arm on 23 Jul 2013. On 24 Jul 2013, he could not open his eyes due to fever. He also had stiff neck, fatigue and lethargy. He could not go for work. He went to emergency room and was treated with TYLENOL. The outcome of the events was reported as complete recovery.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Erythema, Headache, Influenza like illness, Injection site oedema, Nausea
Clinical narrative: Case number PHHY2013US127788 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 498676) website on 11 Nov 2013. This report refers to an 18-year-old female patient. Her medical history included asthma and allergic rhinitis. She was vaccinated with MENVEO (batch number: A11071) intramuscularly into arm on 01 Aug 2013. On 02 Aug 2013, she developed localized erythema and edema at the injection site. She also developed flu-like symptoms approximately 24 hours later with headache, body aches, fever and nausea. She went to emergency room due to these events. No seriousness and causality was reported for the events.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Pain, Pyrexia
Clinical narrative: Case number PHHY2013US127788 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 498676) website on 11 Nov 2013. This report refers to an 18-year-old female patient. Her medical history included asthma and allergic rhinitis. She was vaccinated with MENVEO (batch number: A11071) intramuscularly into arm on 01 Aug 2013. On 02 Aug 2013, she developed localized erythema and edema at the injection site. She also developed flu-like symptoms approximately 24 hours later with headache, body aches, fever and nausea. She went to emergency room due to these events. No seriousness and causality was reported for the events.
Sex: F
Vaccine: HEPA, HPV4, MNQ, TDAP, VARCEL
Symptoms: Abdominal pain upper, Dyspnoea, Erythema, Peripheral swelling, Skin warm
Clinical narrative: Case number PHHY2013US110781, is an initial report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 498749) website on 04 OCT 2013. This report refers to an 11-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M12025) and BOOSTRIX (other manufacturer, batch number AC52B110DA) intramuscularly in the right arm and second dose of VARIVAX (other manufacturer, batch number: H019521) intramuscularly in the right arm, GARDASIL (other manufacturer, batch number: H021346) and HAVRIX (other manufacturer, batch number: AHAVB692BA) intramuscularly in the left arm on 06 AUG 2013. On 07 AUG 2013, she  experienced swollen, red hot arm. She also experienced stomach pain and trouble breathing. The patient recovered on 07 AUG 2013. The seriousness and causality were not reported.
Age: 19.0
Sex: M
Vaccine: MNQ
Symptoms: Expired product administered, No adverse event
Clinical narrative: Case number PHEH2013US017045 is an initial spontaneous report received from a pharmacist on 08 AUG 2013 with a follow up information received from a health care professional on 10 SEP 2013, with a follow up from Vaccine Adverse Event Reporting Systems (VAERS reference number: 498832) website on 11 NOV 2013. This report refers to a 19-years-old male patient. He was vaccinated with an expired dose of MENVEO (batch number: A10047, expiry date DEC 2012) intramuscularly in the deltoid of arm on 08 AUG 2013. No adverse event was reported following this administration error (expired vaccine given).   Follow up information received from a health care professional on 10 SEP 2013. Site of vaccine administration updated.  Follow up was received on 11 NOV 2013. Expiry date of vaccine was updated.
Age: 14.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site oedema, Injection site warmth
Clinical narrative: Case number PHHY2013US127797 is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 498843) web site on 11 Nov 2013. This reports refers to a 14-years-old female patient. Her medical history included scoliosis and she wears Boston brace. She also has mild right ear hearing loss. Her concomitant medications were not reported. She was vaccinated with MENVEO (batch number: A12092) intramuscularly in the left arm on 05 Aug 2013. On 06 Aug 2013, her left upper arm deltoid had edema and 12cmx10cm warm, red area. She went to emergency room for the reaction on 07 Aug 2013. There was no induration and the area was non tender. She denied pain and she was afebrile. She was treated with ibuprofen and ice packs and was advised to call back in case of fever or pain. The outcome was reported as condition unchanged.
Sex: F
Vaccine: HEPA, MNQ, TDAP
Symptoms: Injection site erythema, Injection site warmth, Rash
Clinical narrative: Case number PHHY2013US127803 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS   reference number 498957) website on 11 NOV 2013. This report refers to an 18-years-old female patient. She did not have any known drug allergies and her concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M12127), HAVRIX (other manufacturer, batch number: AHAVB703A) and BOOSTRIX (other manufacturer, batch number: AC52B097CA), all the vaccines administered intramuscularly in the right arm on 07 AUG 2013. On 07 AUG 2013 she experienced erythema and warmth of right upper arm. She was diagnosed with rash. The outcome of the events was reported as complete recovery.
Sex: F
Vaccine: MNQ
Symptoms: Injection site pain, Wrong technique in drug usage process
Clinical narrative: Case number PHHY2013US127804 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 498963) website on 11 NOV 2013. This report refers to a 19-year-old female patient. She received MENA lyophilized conjugate component of MENVEO (batch number: A12025) with plain sterile diluent instead of the men CYW 135 liquid conjugate component, intramuscularly into left arm on 08 AUG 2013. On the same day, she experienced soreness at the injection site. She would return for the complete dose. Outcome of the event was recovered.
Sex: F
Vaccine: HPV4, MNQ, TDAP, VARCEL
Symptoms: Erythema, Pain in extremity, Skin warm
Clinical narrative: Case number PHHY2013YS127814 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 499212) web site on 11 NOV 2013. This report refers to a 12-year-old female patient.  Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number X12013) and BOOSTRIX (other manufacturer, batch number: AC52B097BA) in the right arm and GARDASIL (other manufacturer, batch number: H017698) and VARIVAX (other manufacturer, batch number: 1439AA) in the left arm on 07 AUG 2013. On 07 AUG 2013, she experienced redness and pain on the right arm. The pain started late in the evening of 07 AUG 2013. She had no temperature, but the arm was warm to touch. The outcome of the events was reported as complete recovery.
Age: 12.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Dysuria, Full blood count abnormal, Headache, Pain, Pyrexia
Clinical narrative: Case number PHHY2013US127757, is an initial spontaneous report received from the Vaccine Adverse Event Reporting Sytem (VAERS reference number: 499407) website on 11 NOV 2013. This report refers to a 12-year-old male patient. His historical drug included amoxicillin. He was vaccinated with MENVEO (batch number: A12092) and GARDASIL (batch number: J003727), both in the right arm on 07 AUG 2013 at 3 PM. On the same date, he also received BOOSTRIX (batch number: ZR45M) in the left arm. On the same day evening, he developed headache, fever (101.4) and body aches. He experienced dysuria twice. His urine analysis showed normal result but complete blood count showed more viral shift. He received supportive care as treatment at home. The outcome of the events reported as recovered as of 08 AUG 2013. The seriousness and causality of the events were not reported.
Age: 12.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Urine analysis normal
Clinical narrative: Case number PHHY2013US127757, is an initial spontaneous report received from the Vaccine Adverse Event Reporting Sytem (VAERS reference number: 499407) website on 11 NOV 2013. This report refers to a 12-year-old male patient. His historical drug included amoxicillin. He was vaccinated with MENVEO (batch number: A12092) and GARDASIL (batch number: J003727), both in the right arm on 07 AUG 2013 at 3 PM. On the same date, he also received BOOSTRIX (batch number: ZR45M) in the left arm. On the same day evening, he developed headache, fever (101.4) and body aches. He experienced dysuria twice. His urine analysis showed normal result but complete blood count showed more viral shift. He received supportive care as treatment at home. The outcome of the events reported as recovered as of 08 AUG 2013. The seriousness and causality of the events were not reported.
Sex: F
Vaccine: DTAP, MNQ
Symptoms: Activities of daily living impaired, Inflammation, Pain in extremity, Peripheral swelling, Pruritus
Clinical narrative: Case number PHHY2013US135170 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 499869) website on 25 NOV 2013. This report refers to an 11-year-old female patient. She was vaccinated with DTAP (manufacturer and batch number unknown) and meningococcal vaccine (manufacturer and batch number unknown hence conservatively coded as MENVEO INN, both intramuscularly into left arm on 07 AUG 2013. On the same day, after vaccination , her arm started getting more and more swollen, hot, and very painful. Cold packs were placed on it and gave her ibuprofen. IT just kept getting worse, she missed two days of school because of it and school nurse sent her home and said to apply cold packs and advised that if the same situation continued to go down and started itching, but as of 19 AUG 2013, her arm was still a little swollen, slightly painful and discolored. Outcome of the events was reported as not recovered as of 19 AUG 2013. She also experienced same events recently when she was vaccinated with Td Absorbed (manufacturer and batch number unknown) and also with DTP vaccine/IPV vaccine. No seriousness and causality was reported for the events.
Sex: F
Vaccine: DTAP, MNQ
Symptoms: Skin discolouration, Skin warm
Clinical narrative: Case number PHHY2013US135170 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 499869) website on 25 NOV 2013. This report refers to an 11-year-old female patient. She was vaccinated with DTAP (manufacturer and batch number unknown) and meningococcal vaccine (manufacturer and batch number unknown hence conservatively coded as MENVEO INN, both intramuscularly into left arm on 07 AUG 2013. On the same day, after vaccination , her arm started getting more and more swollen, hot, and very painful. Cold packs were placed on it and gave her ibuprofen. IT just kept getting worse, she missed two days of school because of it and school nurse sent her home and said to apply cold packs and advised that if the same situation continued to go down and started itching, but as of 19 AUG 2013, her arm was still a little swollen, slightly painful and discolored. Outcome of the events was reported as not recovered as of 19 AUG 2013. She also experienced same events recently when she was vaccinated with Td Absorbed (manufacturer and batch number unknown) and also with DTP vaccine/IPV vaccine. No seriousness and causality was reported for the events.
Sex: F
Vaccine: MNQ
Symptoms: Dizziness, Vision blurred, Vomiting
Clinical narrative: Case number PHHY2013US127791 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 499949) website on 11 NOV 2013. This report refers to a 17-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: A121119) intramuscularly in the right arm on 14 AUG 2013. Five minutes after vaccination, she was found to be dizzy, reported blurred vision and vomited on the floor. Outcome of the events was reported as not recovered as of 14 AUG 2013. No seriousness and causality was reported for the events.
Sex: M
Vaccine: HPV4, MNQ, TDAP, VARCEL
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Skin warm
Clinical narrative: Case number PHHY2013US127823 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 500081) website on 11 NOV 2013. This report refers to an 11-years-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number A12125) and BOOSTRIX (other manufacturer, batch number: AC52B092AA) intramuscularly in the left arm and GARDASIL (other manufacturer, batch number: H021608) intramuscularly in the right arm and VARIVAX (other manufacturer, batch number: H018526) subcutaneously in the right arm on 19 AUG 2013. On 19 AUG 2013, she had warmth, significant swelling, redness and pain in left arm. The outcome of the events was reported as complete recovery.
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Discomfort, Injection site erythema, Local reaction, Vaccination site warmth
Clinical narrative: Case number PHHY2013US127839 is an initial spontaneous report received from a consumer (mother of patient) via Vaccine Adverse Event Reporting System (VAERS reference number: 500186) website on 11 NOV 2013. This report refers to a 12-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M11047) intramuscularly in the right arm and VARIVAX (other manufacturer, batch number: H021707) subcutaneously in the right arm on 19 AUG 2013. He also received BOOSTRIX (other manufacturer, batch number: AC52B081AA) intramuscularly administered in his left arm on the same date. On 22 AUG 2013, he experienced a local reaction on his right arm. His mother stated that his vaccination site was red and warm with a diameter of about 5 cm and was worse. The patient was advised to see MD care, fluids and home treatment to ease discomfort. His mother reported that except for local reaction, the child was active, normal, afebrile and was eating well. She stated that she would make an MD appointment. The outcome of the events was reported as condition unchanged.
Age: 16.0
Sex: F
Vaccine: MNQ, VARCEL
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: Case number PHHY2013US127864 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 500513) website on 11 NOV 2013. This report refers to a 16-years-old female patient. Her medical history and concomitant medications were not reported. She was healthy prior vaccination. She was vaccinated with MENVEO (batch number: M12127) intramuscularly in the left arm and VARIVAX (other manufacturer, batch number: H020248) subcutaneously in the left arm on 14 AUG 2013, she had swelling at vaccination site which was warm to touch. The outcome of the events was reported as complete recovery.
Sex: F
Vaccine: HPV2, MNQ
Symptoms: Abnormal behaviour, Fatigue, Memory impairment, Pain in extremity, Speech disorder
Clinical narrative: Case number PHHY2013US127878 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number 500563) website on 11 NOV 2013. This report refers to an 11-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M12027) in the left arm and CERVARIX (other manufacturer, batch number: AHPVA174BJ) in the right arm on 29 JUL 2013. On 30 JUL 2013, she could not think straight. She could not finish sentences. She was very fatigued and could not remember what she was doing. She went to bathroom to brush her teeth and forgot what she was doing She complained to her mother that she could not think straight. It was reported that she acted loopy. She also complained of sore right arm. She did not have any temperature. The outcome of the events was reported as complete recovery as of 12 AUG 2013. The causality and seriousness were not reported.
Sex: F
Vaccine: HPV2, MNQ
Symptoms: Thinking abnormal
Clinical narrative: Case number PHHY2013US127878 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number 500563) website on 11 NOV 2013. This report refers to an 11-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M12027) in the left arm and CERVARIX (other manufacturer, batch number: AHPVA174BJ) in the right arm on 29 JUL 2013. On 30 JUL 2013, she could not think straight. She could not finish sentences. She was very fatigued and could not remember what she was doing. She went to bathroom to brush her teeth and forgot what she was doing She complained to her mother that she could not think straight. It was reported that she acted loopy. She also complained of sore right arm. She did not have any temperature. The outcome of the events was reported as complete recovery as of 12 AUG 2013. The causality and seriousness were not reported.
Sex: M
Vaccine: HEPA, HPV4, MNQ, TDAP, VARCEL
Symptoms: Blister, Erythema, Pain
Clinical narrative: Case number PHHY2013US127879, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number 500873) website on 11 NOV 2013. This report refers to a 14-year-old male patient. He was vaccinated with MENVEO (batch number: M12127) intramuscularly, GARDASIL (batch number: H020901, other manufacturer) intramuscularly and VARIVAX (batch number: H009783, other manufacturer) subcutaneously, all three vaccines in the right arm on 06 AUG 2013. On the same date, he also received HAVRIX (batch number: AHAVB692CA, other manufacturer) and BOOSTRIX (batch number AC52B097AA, other manufacturer) both intramuscularly in the left arm. On the same date, after vaccinations he developed reddened area on the posterior and side of right arm with a quarter size blister and he also had soreness and pain. The patient visited the emergency room. The outcome of the events reported as not recovered. The seriousness and causality of the events were not reported.
Age: 70.0
Sex: M
Vaccine: HEPAB, MNQ, PPV
Symptoms: Dysarthria, Muscular weakness
Clinical narrative: Case number PHHY2013US140055 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS: reference number: 501007) website on 03 DEC 2013. This report refers to a 70-year-old male patient. He was vaccinated with MENVEO (batch number: A11064) into left arm, PNEUMOVAX (other manufacturer, batch number: J004332) into left arm and TWINRIX (other manufacturer, batch number: 4E37E) into right arm on 27 AUG 2013. On 28 AUG 2013, he had muscle weakness and slurred speech and was not sure it was related to the vaccine he received. Outcome of the events was reported as not recovered. No seriousness and causality was reported for the events.
Sex: F
Vaccine: HPV4, MNQ, TDAP, VARCEL
Symptoms: No adverse event, Wrong technique in drug usage process
Clinical narrative: Case number PHHY2013US140123 is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS reference number: 501602) on 03 DEC 2013. This report refers to a 11-years-old female patient. Her medical history included and concomitant medications were not reported. She was vaccinated with MENVEO (batch number A12092) and GARDASIL (other manufacturer, batch number: not reported); both vaccines administered intramuscularly in the left arm and BOOSTRIX (other manufacturer, batch number: 33AG5) intramuscularly and VARIVAX (other manufacturer, batch number: H018791) in the right arm on 03 SEP 2014. It was reported that the Men A power component of MENVEO was diluted with the wrong liquid. No adverse events were reported following the maladministration.
Age: 51.0
Sex: F
Vaccine: MNQ
Symptoms: Axillary pain, Back pain, Erythema, Musculoskeletal pain, Rash
Clinical narrative: Case number PHHY2013US140130 is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS reference number: 501760) on 03 DEC 2013. This report refers to a 51-years-old female patient. Her medical history included and concomitant medications were bot reported. She was vaccinated with MENVEO (batch number: A12119) in the left arm on 12 AUG 2013. On 12 AUG 2013, she had rash, redness, and pain in shoulder, back and under arm. It was reported that she had redness from her shoulder and her vaccination site was tender to touch. She went to emergency room. The outcome of the event was reported as condition unchanged.
Age: 51.0
Sex: F
Vaccine: MNQ
Symptoms: Vaccination site pain
Clinical narrative: Case number PHHY2013US140130 is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS reference number: 501760) on 03 DEC 2013. This report refers to a 51-years-old female patient. Her medical history included and concomitant medications were bot reported. She was vaccinated with MENVEO (batch number: A12119) in the left arm on 12 AUG 2013. On 12 AUG 2013, she had rash, redness, and pain in shoulder, back and under arm. It was reported that she had redness from her shoulder and her vaccination site was tender to touch. She went to emergency room. The outcome of the event was reported as condition unchanged.
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Posture abnormal, Tremor
Clinical narrative: Case number PHHY2013US140141, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 502599) website on 03 DEC 2013. This report refers to 11-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO  (batch number M12130) intramuscularly in the left arm along with GARDASIL (other manufacturer, batch number: H017698) intramuscularly in to the right arm and with BOOSTRIX (other manufacturer, batch number AC52B090BA) intramuscularly in the right arm on an unspecified date at 11:15 AM. After receiving MENVEO vaccine, his head was down and he was leaning forward. He was caught and was laid down. Soon, he started shaking and was taken to the trauma room. He also visited the emergency room. The event outcome was completely recovered. The seriousness and causality was not reported. No additional information was available.
Age: 17.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, VARCEL
Symptoms: Blood creatine phosphokinase increased, Muscular weakness, Pyrexia
Clinical narrative: Case number PHHY2013US140149 is an initial report received from the Vaccine Adverse Event Reporting System (VAERS refer4ence number: 502785) website on 03 DEC 2013. This report refers to 17-years-old female patient. Her medical history and concomitant medications was not reported. She was vaccinated with MENVEO (batch number A12027) and GARDASIL (other manufacturer, batch number: H020002) both vaccines administered intramuscularly in the right arm and BOOSTRIX (other manufacturer, batch number: AC52B090BA) intramuscularly in the left arm and VARIVAX (other manufacturer, batch number: H018759) subcutaneously in the left arm on 08 JUL 2013. On 10 JUL 2013, she experienced a fever with body temperatures of 102 degree C. Fever reducing medications were administered. On 27 JUL 2013, she had muscular weakness which lasted for three weeks. She went to emergency room. Diagnostic laboratory tests were done on an unknown date and it was reported that her creatine phosphokinase (CPK) was elevated (values not reported). The outcome was reported as complete recovery. The seriousness and causality was not reported.
Age: 17.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Chest pain, Fatigue, Headache, Pain in extremity, Rash pruritic
Clinical narrative: Case number PHHY2013US140005 is an initial report received from Vaccine Adverse Event Reporting System (VAERS reference number: 503870) on 03 DEC 2013. This report refers to a 17-year-old male patient. He was vaccinated with MENVEO (batch number M12132, expiry date: not reported), intramuscularly to left arm, VARIVAX (other manufacturer, batch number: J004160; expiry date: not reported) intramuscularly to left arm on 19 SEP 2013. Next day (20 SEP 2013) morning he work up at 6 AM with arms and chest hurting and also felt sluggish. On 21 SEP 2013 he still felt tired. On 22 SEP 2013, he developed an itchy rash that his mom thought it was chickenpox but the rash went away with BENADRYL. A very-itchy hive-like rash "still appears when the next dose of BENADRYL was due". He also had headache with no cough or fever. He was being referred to a healthcare provider for evaluation. Outcome of the events except itchy rash was reported as condition unchanged as of 24 SEP 2013. Seriousness and causality were not reported.
Age: 17.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Sluggishness, Urticaria
Clinical narrative: Case number PHHY2013US140005 is an initial report received from Vaccine Adverse Event Reporting System (VAERS reference number: 503870) on 03 DEC 2013. This report refers to a 17-year-old male patient. He was vaccinated with MENVEO (batch number M12132, expiry date: not reported), intramuscularly to left arm, VARIVAX (other manufacturer, batch number: J004160; expiry date: not reported) intramuscularly to left arm on 19 SEP 2013. Next day (20 SEP 2013) morning he work up at 6 AM with arms and chest hurting and also felt sluggish. On 21 SEP 2013 he still felt tired. On 22 SEP 2013, he developed an itchy rash that his mom thought it was chickenpox but the rash went away with BENADRYL. A very-itchy hive-like rash "still appears when the next dose of BENADRYL was due". He also had headache with no cough or fever. He was being referred to a healthcare provider for evaluation. Outcome of the events except itchy rash was reported as condition unchanged as of 24 SEP 2013. Seriousness and causality were not reported.
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Asthenia, Dizziness, Tremor
Clinical narrative: Case number PHHY2013US1400586 an initial spontaneous report received from Vaccine Adverse Event Reporting System (reference number: 503946) website on 03 DEC 2013. This report refers to a 12-year old female child. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number M12128) in to the right arm along with GARDASIL (other manufacturer, batch number: H017698) in to the right arm and with ADACEL (other manufacturer, batch number: U3979DA) in to the left arm on 20 SEP 2013. All the vaccines were administered intramuscularly. On the same day after vaccinations, she felt dizzy. She was  shaking and was weak after three vaccines were given. Sucker and water was given. She was examined by the nurse practitioner and was then released. Final outcome of the events was reported as complete recovery on an undetermined date. No further information about causality and seriousness was reported.
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Abdominal pain upper, Dizziness, Injection site nerve damage, Pain in extremity
Clinical narrative: Case number PHHY2013US140219 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 504264) website on 03 DEC 2013. This report refers to 11-year-old female patient. Her concurrent condition included latex allergy. Concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M12124) intramuscularly into right arm on 24 SEP 2013. On the same day, she was also vaccinated with BOOSTRIX (other manufacturer and batch number: AC52B088AA) into left arm. On the same day, post vaccinations, she experienced dizziness, stomach pain and radiating pain down right arm. IT was also reported that "needle hit nerve". She was taken to Emergency Room (ER) due to these events. Outcome of the events was reported as recovered. The seriousness and causality of the events was not reported.
Age: 12.0
Sex: U
Vaccine: MNQ
Symptoms: No adverse event, Wrong technique in drug usage process
Clinical narrative: Case number PHHY2014US000758, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 505377) website on 06 JAN 2014. This report refers to a 12-year-old male patient. His medical history and concomitant medications were not reported. He received only MEN C Y W-135 liquid conjugate component of MENVEO ACWY, (batch number X12089) intramuscularly into the right arm without mixing with MEN A component on 16 SEP 2013. He was revaccinated with complete dose of MENVEO (batch number: not reported) on 02 OCT 2013. No adverse event was reported following this administration error.
Age: 18.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Erythema, Peripheral swelling, Skin warm, Upper extremity mass
Clinical narrative: Case number PHHY2014US000768, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 505670) website on 06 JAN 2014. This report refers to a 18-year-old female patient. She was vaccinated with MENVEO (batch number: 505670) in the right arm and GARDASIL (batch number: H021608) in the left arm on an unknown date. On an unknown date, after vaccination she experienced red, round, raised hot lumps on both arms. The final outcome of the events reported as not recovered.
Age: 11.0
Sex: F
Vaccine: FLUN4, HPV4, MNQ
Symptoms: Erythema, Pruritus, Skin warm, Swelling
Clinical narrative: Case number PHHY2014US000799 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (reference number: 507234) website on 06 JAN 2014. This report refers to an 11-year old female patient. Her medical history included tinea versicolor. Her concomitant medications were not reported. She was vaccinated with MENVEO (batch number: A12100) intramuscularly in to the left arm along with GARDASIL (other manufacturer, batch number: H021608) intramuscularly into the right arm and with FLUMIST (other manufacturer, batch number: BH2090) intranasal, on 02 OCT 2013. On the same day after vaccinations,she experienced redness,  heat, swelling and pruritus on an unspecified area. She visited the emergency room (ER) following these events. Final outcome of the events was reported as complete recovery. No further information about seriousness and causality was provided.
Age: 0.02
Sex: F
Vaccine: MNQ
Symptoms: Decreased eye contact
Clinical narrative: Case number PHHY2014US000892 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 507396) website on 06 JAN 2014. This report refers to a 2-month old female baby. Her concurrent conditions and concomitant medications were not reported. She was vaccinated with meningococcal vaccine (unknown manufacturer and batch number) on 20 SEP 2013. Baby stopped making eye contact soon after receiving the shot and was unable to make eye contact for a full three days after the vaccination. Outcome of the event was reported as recovered. Seriousness and causality of the events was not reported.
Age: 12.0
Sex: F
Vaccine: HEPA, MNQ, TDAP
Symptoms: Abdominal pain upper, Headache, Influenza virus test, Pyrexia, Streptococcus test
Clinical narrative: Case number PHHY2014US001174 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (reference number: 508486) website on 06 JAN 2014. This report refers to a 12-year-old female patient. her medical history included Amoxicillin allergy. Her concomitant medications were not reported. She was vaccinated with MENVEO (batch number A12013) intramuscularly in to the right arm along with BOOSTRIX (other manufacturer, batch number: AC52B110DA) intramuscularly in to the left arm with HAVRIX (other manufacturer, batch number:AHAVB703BA) intramuscularly in to the right arm on 03 OCT 2013. Two hours after vaccinations, she complained of stomach ache, headache, and her thighs were painful to touch. She was afebrile, however she developed a fever of 101 degree Celsius 24 to 36 hours after vaccinations. Symptoms did not improve markedly and she was taken to the emergency room (ER) 36 hours after vaccinations. Laboratory tests included urine analysis, flu test and streptococcal test. Results for these tests were not reported. Final outcome of the events was reported as condition unchanged as on 16 OCT 2013. No further information about seriousness and causality was provided.
Age: 12.0
Sex: F
Vaccine: HEPA, MNQ, TDAP
Symptoms: Tenderness, Urine analysis
Clinical narrative: Case number PHHY2014US001174 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (reference number: 508486) website on 06 JAN 2014. This report refers to a 12-year-old female patient. her medical history included Amoxicillin allergy. Her concomitant medications were not reported. She was vaccinated with MENVEO (batch number A12013) intramuscularly in to the right arm along with BOOSTRIX (other manufacturer, batch number: AC52B110DA) intramuscularly in to the left arm with HAVRIX (other manufacturer, batch number:AHAVB703BA) intramuscularly in to the right arm on 03 OCT 2013. Two hours after vaccinations, she complained of stomach ache, headache, and her thighs were painful to touch. She was afebrile, however she developed a fever of 101 degree Celsius 24 to 36 hours after vaccinations. Symptoms did not improve markedly and she was taken to the emergency room (ER) 36 hours after vaccinations. Laboratory tests included urine analysis, flu test and streptococcal test. Results for these tests were not reported. Final outcome of the events was reported as condition unchanged as on 16 OCT 2013. No further information about seriousness and causality was provided.
Sex: M
Vaccine: MNQ
Symptoms: Cold sweat, Fatigue, Feeling cold, Pallor
Clinical narrative: Case number PHHY2014US000796, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 508951) website on 06 JAN 2014. This report refers to an 18-year-old male patient. His medical history and concomitant medication were not reported. He was vaccinated with MENVEO (batch number: A13017) intramuscularly in the left arm on 22 OCT 2013. On the same day after vaccination, he felt really tired, he was pale, cold and clammy. The outcome of the events was reported as completely recovered as of 22 OCT 2013. The seriousness and causality of the events were not reported. No additional information was available.
Sex: F
Vaccine: HEP, IPV, MMR, MNQ
Symptoms: Fatigue, Headache, Measles, Measles post vaccine, Pyrexia
Clinical narrative: Case number PHHY2014US001273, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number509715) website on 06 JAN 2014. This report refers to an 11-year-old female patient. Her medical history and concomitant medication were not reported), ENGERIX-B (other manufacturer, batch number, not reported, hepatitis B), IPOL (other manufacturer, batch number: not reported), MMR II (other manufacturer, batch number: not reported) and BOOSTRIX (other manufacturer, batch number: not reported) intramuscularly in the arm on 14 OCT 2013 respectively. On 21 OCT 2013, she began to feel very tired and had a headache. On 22 OCT 2013, the worsened and spiked a fever at 104. Her mother treated with medications and essential oils and she was better the next 2 days. Fever returned on 25 OCT 2013 and rash appeared that evening. Rash worsened overnight despite BENADRYL. On 26 OCT 2013, physician assistant at an urgent care diagnosed her with measles. No lab tests were performed, just examination and Koplik's spots were noted. The outcome of the events was reported as condition unchanged as of 26 OCT 2013. The seriousness and causality of the events were not reported. No additional information was available.   Following internal review of the data received on 06 JAN 2014. The events fatigue and headache linked under measles.
Sex: F
Vaccine: HEP, IPV, MMR, MNQ
Symptoms: Rash
Clinical narrative: Case number PHHY2014US001273, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number509715) website on 06 JAN 2014. This report refers to an 11-year-old female patient. Her medical history and concomitant medication were not reported), ENGERIX-B (other manufacturer, batch number, not reported, hepatitis B), IPOL (other manufacturer, batch number: not reported), MMR II (other manufacturer, batch number: not reported) and BOOSTRIX (other manufacturer, batch number: not reported) intramuscularly in the arm on 14 OCT 2013 respectively. On 21 OCT 2013, she began to feel very tired and had a headache. On 22 OCT 2013, the worsened and spiked a fever at 104. Her mother treated with medications and essential oils and she was better the next 2 days. Fever returned on 25 OCT 2013 and rash appeared that evening. Rash worsened overnight despite BENADRYL. On 26 OCT 2013, physician assistant at an urgent care diagnosed her with measles. No lab tests were performed, just examination and Koplik's spots were noted. The outcome of the events was reported as condition unchanged as of 26 OCT 2013. The seriousness and causality of the events were not reported. No additional information was available.   Following internal review of the data received on 06 JAN 2014. The events fatigue and headache linked under measles.
Age: 12.0
Sex: M
Vaccine: FLU3, HPV4, MNQ
Symptoms: Erythema, Peripheral swelling, Skin warm
Clinical narrative: Case number  PHHY2014YS001304 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS number: 509755) website on 06 JAN 2014. This report refers to a 12-year-old male patient. His medical history was not reported. Historical medication included Azithromycin. This poly medicated patient was vaccinated with MENVEO (batch number: A12120) along with GARDASIL (other manufacturer, batch  number J006850) and with FLUARIX (other manufacturer, batch number SEE73) on 23 OCT 2013. All the vaccines were administered intramuscularly. ON an undetermined date after vaccinations, he experienced redness, swelling and warmth of about three inches (oval in shape) on the right arm. Final outcome of the events was reported as condition unchanged as on 23 OCT 2013. No further information about seriousness and causality was provided.
Age: 11.0
Sex: U
Vaccine: MNQ
Symptoms: Adverse reaction, Incorrect route of drug administration
Clinical narrative: Case number PHHY2014US013415, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 513290) website on 03 FEB 2014. This report refers to a 11-year-old male patient. He was vaccinated with MENVEO (batch number: M12124) subcutaneous in the left arm on 11 NOV 2013. On the same date, he experienced a reaction overnight which was small and it became bigger the next day. The final outcome of the event reported as recovered. The seriousness and causality of the event were not reported.   Following an internal review , a significant correction was done for the information received on 03 FEB 2014. Added event (wrong route of administration).
Age: 40.0
Sex: F
Vaccine: MNQ
Symptoms: Chills, Headache, Hypotension, Laboratory test normal, Nausea
Clinical narrative: Case number PHHY2014US006620, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 513357) website on 20 Jan 2014. This report refers to a 40-year-old female patient. She was vaccinated with meningococcal vaccine (manufacturer and batch number: not reported, so conservatively coded as MENVEO) on 13 Nov 2013. In 14 Nov 2013, she experienced fever, headache, rigors, nausea, vomiting and hypotension. She visited the emergency room and all the septic work up showed negative results. The final outcome of the events reported as not recovered. The seriousness and causality of the events were not reported.
Age: 40.0
Sex: F
Vaccine: MNQ
Symptoms: Pyrexia, Vomiting
Clinical narrative: Case number PHHY2014US006620, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 513357) website on 20 Jan 2014. This report refers to a 40-year-old female patient. She was vaccinated with meningococcal vaccine (manufacturer and batch number: not reported, so conservatively coded as MENVEO) on 13 Nov 2013. In 14 Nov 2013, she experienced fever, headache, rigors, nausea, vomiting and hypotension. She visited the emergency room and all the septic work up showed negative results. The final outcome of the events reported as not recovered. The seriousness and causality of the events were not reported.
Age: 21.0
Sex: F
Vaccine: MNQ
Symptoms: Blood test normal, Diarrhoea, Erythema, Headache, Hypotension
Clinical narrative: Case number PHHY2014US013877 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 514038) on 03 FEB 2014. This report refers to a 21-year-old female patient. Her medical history and concomitant medications were not report4ed. She was vaccinated with MENVEO (batch number: M13011) intramuscularly in the left arm on 12 NOV 2013. On 14 NOV 2013, she had an adverse reaction to the vaccine which was further described as headache, nausea, diarrhea, arm felt heavy not hot, red and swollen. She went to emergency room and her blood pressure was low (results were not reported). Intravenous fluids were given and released. She was treated with ibuprofen for 3 days (3 every 6 hours). Blood work was done and the results were normal. The event outcome was reported as condition unchanged. The seriousness and causality of the event were not reported.
Age: 21.0
Sex: F
Vaccine: MNQ
Symptoms: Limb discomfort, Nausea, Peripheral swelling, Skin warm
Clinical narrative: Case number PHHY2014US013877 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 514038) on 03 FEB 2014. This report refers to a 21-year-old female patient. Her medical history and concomitant medications were not report4ed. She was vaccinated with MENVEO (batch number: M13011) intramuscularly in the left arm on 12 NOV 2013. On 14 NOV 2013, she had an adverse reaction to the vaccine which was further described as headache, nausea, diarrhea, arm felt heavy not hot, red and swollen. She went to emergency room and her blood pressure was low (results were not reported). Intravenous fluids were given and released. She was treated with ibuprofen for 3 days (3 every 6 hours). Blood work was done and the results were normal. The event outcome was reported as condition unchanged. The seriousness and causality of the event were not reported.
Age: 18.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Inflammation, Injection site erythema
Clinical narrative: Case number PHEH2013US024649 is an initial spontaneous report received from a physician via nurse on 21 NOV 2013. This report refers to an 18-years-old female patient. She had a past medical history of acne and sensitive skin. She had a boil outbreak, one month before vaccine administration. On 05 NOV 2013, she was vaccinated with MENVEO (batch number: M13011) intramuscularly. On the same date after vaccination, she experienced a red inflammatory "C-shaped" lesion slightly to the left of the injection site. Nurse advised her to apply ice at the injection site and to take ibuprofen, but she refused to do so. On an unknown date, her lesion was healed and she had no complaints. The causality and seriousness of the events were not assessed.
Age: 18.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Injection site erythema, Injection site inflammation, Injection site reaction, Skin lesion
Clinical narrative: Case number PHEH2013US024649 is an initial spontaneous report received from a physician via nurse on 21 NOV 2013. This report refers to an 18-years-old female patient. She had a past medical history of acne and sensitive skin. She had a boil outbreak, one month before vaccine administration. On 05 NOV 2013, she was vaccinated with MENVEO (batch number: M13011) intramuscularly. On the same date after vaccination, she experienced a red inflammatory "C-shaped" lesion slightly to the left of the injection site. Nurse advised her to apply ice at the injection site and to take ibuprofen, but she refused to do so. On an unknown date, her lesion was healed and she had no complaints. The causality and seriousness of the events were not assessed.